| 0 | ℹ |
Pharmacologically targeting CDK12 induces BRCAness and synergizes with merestinib to exacerbate DNA damage in high-risk neuroblastoma.
(linkinghub.elsevier.com)
|
Cell Reports 2026-10-12 | #neuroblastoma #cancer #dna damage #combination therapy #cdk12 |